Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laura May Davis"'
Autor:
Laura May Davis, Misun Hwang
Publikováno v:
Metabolites, Vol 14, Iss 8, p 412 (2024)
Hemorrhagic hydrocephalus is a common pathology in neonates with high mortality and morbidity. Current imaging approaches fail to capture the mechanisms behind its pathogenesis. Here, we discuss the processes underlying this pathology, the metabolic
Externí odkaz:
https://doaj.org/article/9e92865e7bd6454c9281a0817a15ff21
Autor:
N Nicou, Nicola Mulholland, Rajaventhan Srirajaskanthan, Laura May Davis, Wendy Martin, Ben Corcoran, John Ramage, Olaf Wendler, Gill Vivian
Publikováno v:
Nuclear Medicine Communications. 41:575-581
Introduction Perioperative mortality of patients who undergo heart valve surgery for carcinoid heart valve disease has been observed to be high (5%-10%). We investigated whether peptide receptor radiotherapy with lutetium-177 dotatate can be used saf
Autor:
Arjun Nair, Alexander Procter, Steve Halligan, Thomas Parry, Asia Ahmed, Mark Duncan, Magali Taylor, Manil Chouhan, Trevor Gaunt, James Roberts, Niels van Vucht, Alan Campbell, Laura May Davis, Joseph Jacob, Rachel Hubbard, Shankar Kumar, Ammaarah Said, Xinhui Chan, Tim Cutfield, Akish Luintel, Michael Marks, Neil Stone, Sue Mallet
Publikováno v:
European radiology.
Objectives To quantify reader agreement for the British Society of Thoracic Imaging (BSTI) diagnostic and severity classification for COVID-19 on chest radiographs (CXR), in particular agreement for an indeterminate CXR that could instigate CT imagin
Autor:
Wendy Martin, Ben Corcoran, Nicola Mulholland, Rajaventhan Srirajaskanthan, N Nicou, Gill Vivian, Laura May Davis, Olaf Wendler, John Ramage
Publikováno v:
Endocrine Abstracts.
Introduction Perioperative mortality of patients who undergo heart valve surgery for carcinoid heart valve disease has been observed to be high (5%-10%). We investigated whether peptide receptor radiotherapy with lutetium-177 dotatate can be used saf
Autor:
Mohamed Bakhit, Dylan Lewis, Paul Ross, Andreas Prachalias, Johnathan G.H. Hubbard, Debashis Sarker, Jennifer Clough, Simon Aylwin, Norman T Taylor, Laura May Davis, Gillian Vivian, Benjamin Whitelaw, Jackie Gilbert, David R Taylor, Lea Ghatore, Klaus-Martin Schulte, Salvador J. Diaz-Cano, Patsy Coskeran, Gabriele Galata
Publikováno v:
Endocrine Abstracts.
Introduction: Multi-modal therapy for adrenocortical carcinoma (ACC) includes surgery, therapy with the adrenolytic agent mitotane and systemic chemotherapy. Achievement of therapeutic mitotane concentrations (≥14 mg/l) has been related to improved
Publikováno v:
Endocrine Abstracts.